Research

Research at PIPRA
Our vision is to provide clinically validated digital tools to better predict,diagnose, treat and prevent delirium. We will accomplish this in collaboration with our clinical research partners, and through clinical trials, peer-reviewed publications, and continued consultation with key opinion leaders.
Our Publications
Exploratory Budget Impact Analysis of a Preoperative Risk Assessment for Postoperative Delirium
Kempers, J.
View publication
Preoperative prognostic factors associated with postoperative delirium in older people undergoing surgery: protocol for a systematic review and individual patient data meta-analysis.
Buchan, T.A., Sadeghirad, B., Schmutz, N. et al. Syst Rev 9, 261 (2020). https://doi.org/10.1186/s13643-020-01518-
View publication
Our Research Activities
Our Research Collaborations:
Validation of a Risk Assessment Model for Postoperative Delirium Based on Artificial Intelligence
In collaboration with:
University HospitalBasel, Hôpitaux Universitaires de Genève, CentreHospitalier Universitaire Vaudois
Funded by: Innosuisse
ClinicalTrials.gov Identifier: NCT05639348
University HospitalBasel, Hôpitaux Universitaires de Genève, CentreHospitalier Universitaire Vaudois
Funded by: Innosuisse
ClinicalTrials.gov Identifier: NCT05639348
PIPRA Research News
Bringing together the visionary minds designing the future of Age-Tech for Japan and the rest of the world.
Der IFASinnovation Challenge Award wird im Rahmen der IFAS Expo vergeben. Die Challenge richtet sich an Start-Ups, mit einer visionären Idee, einer herausragenden Dienstleistung oder einem innovativen Projekt bzw. Produkt, die im Schweizer Gesundheitswesen Fuss fassen wollen.
On 26-27 Sept 2022 Nayeli Schmutz was at the AUTOMA Health 2022 conference speaking during Leaders Talk 2 about “Social aspects of digitalization” with the topic "Decreasing the Stress and Burden of Delirium through Digitalization", followed by a panel discussion.
PIPRA has recently closed a successful seed round of international investment, led by Starts Angels Network, and raised €2.1 million.